1. Home
  2. MYGN vs TLS Comparison

MYGN vs TLS Comparison

Compare MYGN & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

N/A

Current Price

$5.68

Market Cap

372.1M

Sector

Health Care

ML Signal

N/A

Logo Telos Corporation

TLS

Telos Corporation

N/A

Current Price

$7.41

Market Cap

358.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
MYGN
TLS
Founded
1991
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
372.1M
358.0M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
MYGN
TLS
Price
$5.68
$7.41
Analyst Decision
Hold
Buy
Analyst Count
9
6
Target Price
$5.44
★ $8.58
AVG Volume (30 Days)
★ 2.9M
1.1M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 31.51
EPS
N/A
★ 0.09
Revenue
★ $771,400,000.00
$164,805,000.00
Revenue This Year
N/A
$20.11
Revenue Next Year
N/A
$1.00
P/E Ratio
★ N/A
$85.78
Revenue Growth
2.33
★ 52.21
52 Week Low
$2.74
$3.79
52 Week High
$8.09
$7.96

Technical Indicators

Market Signals
Indicator
MYGN
TLS
Relative Strength Index (RSI) 53.36 72.30
Support Level $4.24 $4.02
Resistance Level $6.34 N/A
Average True Range (ATR) 0.38 0.54
MACD -0.12 0.25
Stochastic Oscillator 12.69 83.53

Price Performance

Historical Comparison
MYGN
TLS

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About TLS Telos Corporation

Telos Corp offers technology solutions and services that empower and protect the world's security-conscious organizations. The company delivers efficient, adaptable, and secure solutions that protect people, organizations, and information across government and industry. The company conducts its business through two reportable and operating segments: Security Solutions and Secure Networks. The Security Solutions segment is focused on cybersecurity, cloud, and identity solutions, and secure messaging through Xacta, Telos AMHS, and Telos ID offerings. The Secure Networks segment provides secure networking architectures and solutions to customers through secure mobility solutions, network management, and defense services. The majority of revenue is from Secure Networks.

Share on Social Networks: